Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2026 10:30 ET | Source: SNS Insider pvt ltd

Variable Frequency Drive (VDF) Market Size to Worth $45.60 Billion by 2035 | SNS Insider

Variable Frequency Drive (VFD) Market Size, Share, Trends & Segmentation Analysis, By Product, Range, Application, End Use, and Regions | Forecast 2035
March 25, 2026 10:00 ET | Source: eGain Corporation

eGain Launches AI Knowledge Suite for Retail Banking to Drive Growth, Satisfaction, and Compliance

eGain launches AI Knowledge Suite for Retail Banking with AscentAI and HERE to help banks and credit unions boost revenue, CX, and compliance.
March 25, 2026 09:04 ET | Source: InnoCare Pharma

InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual...
March 25, 2026 09:00 ET | Source: Frequency Electronics, Inc.

Frequency Electronics Inc. Announces Space Mission Contract Award Valued at Approximately $7 million

MITCHEL FIELD, N.Y., March 25, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for...
March 25, 2026 08:00 ET | Source: ProMIS Neurosciences Inc.

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

PRECISE-AD Phase 1b trial fully enrolled. Completion of six-month assessments expected in Q2 2026 with blinded interim analysis anticipated early Q3 2026; twelve-month top-line data anticipated in...
March 25, 2026 08:00 ET | Source: Anaplan

Anaplan Announces Latest AI-Driven Innovations and Applications to Advance Enterprise Decision-Making

MIAMI, March 25, 2026 (GLOBE NEWSWIRE) -- Anaplan, a leading AI-driven scenario planning and analysis platform designed to optimize decision-making in today’s complex business environment, today...
March 25, 2026 07:31 ET | Source: Vanderbilt Report and Artelo Biosciences

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

BRISTOL, Tenn., March 25, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) is drawing increased attention following its expansion into the $16.3 billion glaucoma market through a...
March 25, 2026 07:30 ET | Source: EDAP TMS S.A.

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of...
March 25, 2026 07:00 ET | Source: NetraMark Holdings Inc.

NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company...
March 25, 2026 07:00 ET | Source: Beam Therapeutics

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM Protective AAT Threshold with up to 12 Months of...